0

Pharmaceutical Contract Research and Manufacturing Market by Service and Geography - Forecast and Analysis 2021-2025

  • Published: Sep 2021
  • Pages: 125
  • SKU: IRTNTR41601
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The pharmaceutical contract research and manufacturing (CRAM) market share is expected to increase by USD 96.18 billion from 2020 to 2025, and the market's growth momentum will decelerate at a CAGR of 10%.

This pharmaceutical contract research and manufacturing (CRAM) market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers pharmaceutical contract research and manufacturing (CRAM) market segmentations by service (CMO and CRO) and geography (North America, Asia, Europe, and ROW). The pharmaceutical contract research and manufacturing (CRAM) market report also offers information on several market vendors, including Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc. among others.

What will the Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size be During the Forecast Period?

Pharmaceutical Contract Research and Manufacturing Market Size

Download the Free Report Sample to Unlock the Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size for the Forecast Period and Other Important Statistics

 

Pharmaceutical Contract Research and Manufacturing (CRAM) Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The availability of cost-efficient resources in emerging markets is notably driving the pharmaceutical contract research and manufacturing (CRAM) market growth, although factors such as stereotypical nature of cmos may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the pharmaceutical contract research and manufacturing (CRAM) industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Pharmaceutical Contract Research and Manufacturing (CRAM) Market Driver

One of the key factors driving the pharmaceutical contract research and manufacturing (CRAM) market growth is the availability of cost-efficient resources in emerging markets. Countries such as China, India, Brazil, and Mexico have witnessed significant advances in their healthcare infrastructure and technological advances in their drug development processes. As a result, large and medium-sized pharmaceutical companies from developed countries are outsourcing the research and manufacturing operations of various drugs and therapies to the vendors in such countries. One of the key reasons for the increasing popularity of outsourcing these processes is the availability of labor at a comparatively lower price than in developed countries. Factors  such as the increasing number of US FDA-approved manufacturing plants in such countries also encourage outsourcing. For instance, India, which is one of the most preferred countries for CMO, has more than 100 US FDA-approved manufacturing facilities, and the number of such facilities has increased in the country. Therefore, the global pharmaceutical CRAM market is expected to grow strongly during the forecast period.

Key Pharmaceutical Contract Research and Manufacturing (CRAM) Market Trend

Another key factor driving the pharmaceutical contract research and manufacturing (CRAM) market growth is the patent cliff. Patent expiry leads to the loss of market exclusivity of approved drugs and creates opportunities for the entry of generic drugs and biosimilars, which are priced at a lower rate. The generic versions of these drugs, despite having similar efficacy as the original drug, cost less, resulting in value erosion of the global market. Due to the low cost and profit margins associated with generics, various large pharmaceutical companies outsource the manufacturing process of their generic drugs to CMOs in emerging countries such as India. This process is outsourced to the CMOs in the emerging countries due to the low cost of manufacturing, availability of labor, and ease of distribution, as the market in Asia is largely dominated by generic drugs. Moreover, as a result of the looming patent cliff and the cost-effective nature of generics, the pharmaceutical market is also witnessing an increasing adoption of generic drugs in the US and in the developed countries of Europe. Hence, the market opportunity for CMOs is increasing in these regions.

Key Pharmaceutical Contract Research and Manufacturing (CRAM) Market Challenge

Stereotypical nature of CMOs is one of the key challenges hindering the pharmaceutical contract research and manufacturing (CRAM) market growth. Despite recent advances in the healthcare infrastructure, CMOs in Asia, which holds the highest share of the global CMO market, lack access to advanced technologies. Hence, they use older technologies to manufacture drugs. CMOs in the region mostly manufacture small molecule-based drugs, which can be produced in large quantities. These CMOs lack the ability to produce biological drugs and vaccines on a large scale. This is primarily due to the complex manufacturing processes of biological drugs, which require advanced technologies. The cost of manufacturing such drugs is also usually high. Many global CMOs operating on a small scale lack the funding required to produce biological drugs on a large scale. As a result, the growth opportunity for the small and medium-sized CMOs is restricted to the growth of small molecule-based generic drugs. This is currently a major challenge faced by CMOs, which is expected to significantly hinder the growth of the global pharmaceutical CRAM market during the forecast period.

This pharmaceutical contract research and manufacturing (CRAM) market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global pharmaceutical contract research and manufacturing (CRAM) market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the pharmaceutical contract research and manufacturing (CRAM) market during the forecast period.

Who are the Major Pharmaceutical Contract Research and Manufacturing (CRAM) Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddys Laboratories Ltd.
  • Icon Plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Thermo Fisher Scientific Inc.

This statistical study of the pharmaceutical contract research and manufacturing (CRAM) market encompasses successful business strategies deployed by the key vendors. The pharmaceutical contract research and manufacturing (CRAM) market is fragmented and the vendors are deploying growth strategies such as organic and inorganic strategies to compete in the market.

Product Insights and News

  • Boehringer Ingelheim International GmbH - The company offers includes the manufacturing of human pharmaceutical products, animal pharmaceutical products, and biopharmaceuticals on a contract basis for other vendors.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The pharmaceutical contract research and manufacturing (CRAM) market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Pharmaceutical Contract Research and Manufacturing (CRAM) Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the pharmaceutical contract research and manufacturing (CRAM) market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Pharmaceutical Contract Research and Manufacturing (CRAM) Market?

Pharmaceutical Contract Research and Manufacturing Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

35% of the market's growth will originate from Asia during the forecast period. India and China are the key markets for pharmaceutical contract research and manufacturing (CRAM) in Asia. Market growth in this region will be faster than the growth of the market in other regions.

North America accounted for another significant region in the global pharmaceutical CRAM market, primarily due to the strong CRO segment in the region and the growing popularity of CMOs in the US and Mexico. North America dominates the CRO segment of the global pharmaceutical CRAM market due to the presence of various large-scale CROs in the US. For instance, IQVIA, which is the world's largest CRO, is headquartered in the US and is known to provide R&D solutions to various large pharmaceutical vendors globally. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 adversely affected all countries in North America, especially the US. However, the pandemic positively impacted the pharmaceutical CRAM market in North America. Owing to the pandemic, lockdowns were imposed in countries such as Canada and Mexico, besides the US. Thus, people started stocking up on essential items, including pharmaceuticals. This further led to a higher-than-usual rise in the demand for pharmaceuticals. Thus, to meet the demand-supply gap with regard to pharmaceuticals in the region, the demand for pharmaceutical CRAM increased significantly in 2020. This resulted in the significant market growth in 2020. Furthermore, the market is expected to register a positive growth rate during the forecast period, owing to the constant efforts to contain the spread of the disease. In June 2020, Catalent Inc. signed an agreement with Spicona to develop a virus-like protein-based vaccine against COVID-19 by utilizing its proprietary GPEx cell line development technology to develop a cell line expressing the recombinant VLP at its facility in the US. Such strategies can accelerate the manufacturing of vaccines for the COVID-19 pandemic. Therefore, the pharmaceutical CRAM market in the region is expected to grow during the forecast period.

What are the Revenue-generating Service Segments in the Pharmaceutical Contract Research and Manufacturing (CRAM) Market?

Pharmaceutical Contract Research and Manufacturing Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The pharmaceutical contract research and manufacturing (CRAM) market share growth by the CMO will be significant during the forecast period. CMOs are organizations that manufacture drugs and other pharmaceutical therapies such as vaccines and healthcare products on a contract basis for pharmaceutical vendors and biotechnology companies. The CMO segment of the global pharmaceutical CRAM market has witnessed significant growth in recent years, owing to the increasing trend of outsourcing the manufacture of various small molecules and biologic drugs by pharmaceutical vendors globally.

Besides the above-mentioned factors, the post COVID-19 impact has brought forth a slowdown in or fast tracked the demand for the service or product. This report provides an accurate prediction of the contribution of all the segments to the growth of the pharmaceutical contract research and manufacturing (CRAM) market size and actionable market insights on post COVID-19 impact on each segment.

 

Pharmaceutical Contract Research and Manufacturing (CRAM) Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Decelerate at a CAGR of 10%

Market growth 2021-2025

$ 96.18 billion

Market structure

Fragmented

YoY growth (%)

12.22

Regional analysis

North America, Asia, Europe, and ROW

Performing market contribution

Asia at 35%

Key consumer countries

US, India, China, Germany, UK, and France

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Pharmaceutical Contract Research And Manufacturing (CRAM) Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive pharmaceutical contract research and manufacturing (CRAM) market growth during the next five years
  • Precise estimation of the pharmaceutical contract research and manufacturing (CRAM) market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the pharmaceutical contract research and manufacturing (CRAM) industry across North America, Asia, Europe, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of pharmaceutical contract research and manufacturing (CRAM) market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
  • 2.2 Value chain analysis
    • Exhibit 02: Market characteristics
    • Exhibit 03: Value chain analysis: Pharmaceuticals

3 Market Sizing

  • 3.1 Market definition
    • 3.2 Market segment analysis
      • Exhibit 04: Offerings of vendors included in the market definition
    • 3.3 Market size 2020
      • Exhibit 05: Market segments
    • 3.4 Market outlook: Forecast for 2020 - 2025
      • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ billion)

    4 Five Forces Analysis

    • 4.1 Five forces analysis 2020 & 2025
      • 4.2 Bargaining power of buyers
        • Exhibit 08: Five forces analysis 2020 & 2025
      • 4.3 Bargaining power of suppliers
        • Exhibit 09: Bargaining power of buyers
      • 4.4 Threat of new entrants
        • Exhibit 10: Bargaining power of suppliers
      • 4.5 Threat of substitutes
        • Exhibit 11: Threat of new entrants
      • 4.6 Threat of rivalry
        • Exhibit 12: Threat of substitutes
      • 4.7 Market condition
        • Exhibit 13: Threat of rivalry

      5 Market Segmentation by Service

      • 5.1 Market segments
        • Exhibit 15: Service - Market share 2020-2025 (%)
      • 5.2 Comparison by Service
        • 5.3 CMO - Market size and forecast 2020-2025
          • Exhibit 16: Comparison by Service
          • Exhibit 17: CMO - Market size and forecast 2020-2025 ($ billion)
        • 5.4 CRO - Market size and forecast 2020-2025
          • Exhibit 18: CMO - Year-over-year growth 2020-2025 (%)
          • Exhibit 19: CRO - Market size and forecast 2020-2025 ($ billion)
        • 5.5 Impact of COVID-19 on the segment
          • Exhibit 20: CRO - Year-over-year growth 2020-2025 (%)
        • 5.6 Market opportunity by Service

          6 Customer landscape

          • 6.1 Customer landscape

            7 Geographic Landscape

            • 7.1 Geographic segmentation
              • Exhibit 23: Market share by geography 2020-2025 (%)
            • 7.2 Geographic comparison
              • 7.3 North America - Market size and forecast 2020-2025
                • Exhibit 24: Geographic comparison
                • Exhibit 25: North America - Market size and forecast 2020-2025 ($ billion)
              • 7.4 Asia - Market size and forecast 2020-2025
                • Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
                • Exhibit 27: Asia - Market size and forecast 2020-2025 ($ billion)
              • 7.5 Europe - Market size and forecast 2020-2025
                • Exhibit 28: Asia - Year-over-year growth 2020-2025 (%)
                • Exhibit 29: Europe - Market size and forecast 2020-2025 ($ billion)
              • 7.6 ROW - Market size and forecast 2020-2025
                • Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)
                • Exhibit 31: ROW - Market size and forecast 2020-2025 ($ billion)
              • 7.7 Key leading countries
                • Exhibit 32: ROW - Year-over-year growth 2020-2025 (%)
              • 7.8 Market opportunity by geography
                • Exhibit 33: Key leading countries

              8 Drivers, Challenges, and Trends

              • 8.1 Market drivers
                • 8.2 Market challenges
                  • 8.3 Market trends
                    • Exhibit 35: Impact of drivers and challenges

                  9 Vendor Landscape

                  • 9.1 Overview
                    • 9.2 Landscape disruption
                      • Exhibit 36: Vendor landscape
                      • Exhibit 37: Landscape disruption

                    10 Vendor Analysis

                    • 10.1 Vendors covered
                      • Exhibit 39: Vendors covered
                    • 10.2 Market positioning of vendors
                      • 10.3 Almac Group Ltd.
                        • Exhibit 40: Market positioning of vendors
                        • Exhibit 41: Almac Group Ltd. - Overview
                        • Exhibit 42: Almac Group Ltd. - Product and service
                      • 10.4 Boehringer Ingelheim International GmbH
                        • 10.5 Cadila Healthcare Ltd.
                          • Exhibit 46: Boehringer Ingelheim International GmbH - Key news
                          • Exhibit 47: Boehringer Ingelheim International GmbH - Key offerings
                          • Exhibit 48: Boehringer Ingelheim International GmbH - Segment focus
                          • Exhibit 49: Cadila Healthcare Ltd. - Overview
                          • Exhibit 50: Cadila Healthcare Ltd. - Business segments
                        • 10.6 Catalent Inc.
                          • Exhibit 51: Cadila Healthcare Ltd. - Key offerings
                          • Exhibit 52: Cadila Healthcare Ltd. - Segment focus
                          • Exhibit 53: Catalent Inc. - Overview
                          • Exhibit 54: Catalent Inc. - Business segments
                          • Exhibit 55: Catalent Inc. - Key news
                        • 10.7 Dr. Reddys Laboratories Ltd.
                          • Exhibit 56: Catalent Inc. - Key offerings
                          • Exhibit 57: Catalent Inc. - Segment focus
                          • Exhibit 58: Dr. Reddys Laboratories Ltd. - Overview
                          • Exhibit 59: Dr. Reddys Laboratories Ltd. - Business segments
                        • 10.8 Icon Plc
                          • Exhibit 60: Dr. Reddys Laboratories Ltd. - Key offerings
                          • Exhibit 61: Dr. Reddys Laboratories Ltd. - Segment focus
                          • Exhibit 62: Icon Plc - Overview
                          • Exhibit 63: Icon Plc - Product and service
                        • 10.9 IQVIA Holdings Inc.
                          • Exhibit 64: Icon Plc - Key news
                          • Exhibit 65: Icon Plc - Key offerings
                          • Exhibit 66: IQVIA Holdings Inc. - Overview
                          • Exhibit 67: IQVIA Holdings Inc. - Business segments
                        • 10.10 Laboratory Corp. of America Holdings
                          • Exhibit 68: IQVIA Holdings Inc. - Key news
                          • Exhibit 69: IQVIA Holdings Inc. - Key offerings
                          • Exhibit 70: IQVIA Holdings Inc. - Segment focus
                          • Exhibit 71: Laboratory Corp. of America Holdings - Overview
                          • Exhibit 72: Laboratory Corp. of America Holdings - Business segments
                        • 10.11 Lonza Group Ltd.
                          • Exhibit 73: Laboratory Corp. of America Holdings - Key offerings
                          • Exhibit 74: Laboratory Corp. of America Holdings - Segment focus
                        • 10.12 Thermo Fisher Scientific Inc.
                          • Exhibit 75: Lonza Group Ltd. - Overview
                          • Exhibit 76: Lonza Group Ltd. - Product and service
                          • Exhibit 77: Lonza Group Ltd. - Key offerings
                          • Exhibit 78: Thermo Fisher Scientific Inc. - Overview
                          • Exhibit 79: Thermo Fisher Scientific Inc. - Business segments

                        11 Appendix

                        • 11.1 Scope of the report
                          • 11.2 Currency conversion rates for US$
                            • Exhibit 82: Currency conversion rates for US$
                          • 11.3 Research methodology
                            • Exhibit 83: Research Methodology
                            • Exhibit 84: Validation techniques employed for market sizing
                          • 11.4 List of abbreviations
                            • Exhibit 85: Information sources
                            • Exhibit 86: List of abbreviations

                          Research Framework

                          Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                          TechnavioINFORMATION SOURCES

                          Primary sources

                          • Manufacturers and suppliers
                          • Channel partners
                          • Industry experts
                          • Strategic decision makers

                          Secondary sources

                          • Industry journals and periodicals
                          • Government data
                          • Financial reports of key industry players
                          • Historical data
                          • Press releases
                          Technavio

                          TechnavioDATA ANALYSIS

                          Data Synthesis

                          • Collation of data
                          • Estimation of key figures
                          • Analysis of derived insights

                          Data Validation

                          • Triangulation with data models
                          • Reference against proprietary databases
                          • Corroboration with industry experts
                          Technavio

                          TechnavioREPORT WRITING

                          Qualitative

                          • Market drivers
                          • Market challenges
                          • Market trends
                          • Five forces analysis

                          Quantitative

                          • Market size and forecast
                          • Market segmentation
                          • Geographical insights
                          • Competitive landscape
                          Interested in this report?
                          Get your sample now!
                          Pharmaceutical CRAM Market market growth will increase by $96.18 bn during 2021-2025.
                          The pharmaceutical cram market market is expected to grow at a CAGR of 10% during 2021-2025.
                          Technavio has segmented the pharmaceutical cram market market by service (CMO and CRO) ,geography (North America, APAC, Europe, and ROW) , and geographic (North America, APAC, and Europe).
                          Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddy's Laboratories Ltd., ICON Plc, IQVIA Holding Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., PRA Health Sciences Inc., Thermo Fisher Scientific Inc. are a few of the key vendors in the pharmaceutical cram market market.
                          Asia will register the highest growth rate of 35% among the other regions. Therefore, the pharmaceutical cram market market in Asia is expected to garner significant business opportunities for the vendors during the forecast period.
                          The key factors driving the pharmaceutical cram market market growth are:
                          • availability of cost-efficient resources in emerging markets
                          • patent cliff
                          The pharmaceutical cram market market vendors should focus on grabbing business opportunities from the cmo segment as it accounted for the largest market share in the base year.
                          • What are the key global market and the regional market share?
                          • What are the revenue-generating key market segments?
                          • What are the key factors driving and challenging this market’s growth?
                          • Who are the key market vendors and their growth strategies?
                          • What are the latest trends influencing the growth of this market?
                          • What are the variables influencing the market growth in the primary regions?
                          • What are the factors influencing the growth of the parent market?
                          • Off-the-shelf research reports
                          • Reports can be tailored to meet the customer's needs
                          • Trusted by more than 100 fortune 500 organizations
                          • Information about the market's key drivers, trends, and challenges
                          • Parent market analysis
                          • Every week, 50,000 people visit our subscription platform
                          • Detailed vendors report with competitive landscape
                          • Covid-19 impact and recovery analysis
                          • Data on revenue-generating market segments
                          • Details on the market shares of various regions
                          • Five-force market analysis

                          Certified ISO 9001 : 2015

                          We are ISO recognized

                          We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                          We are GDPR and CCPA compliant

                          We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                          Safe and Secure SSL Encrypted
                          Technavio

                          info
                          close
                          • Single:

                            One user only.
                            Quick & easy download option

                          • Enterprise:

                            Unlimited user access (Within your organization)
                            Complimentary Customization Included

                          2500 USD

                          Technavio Get the report (PDF) sent to your email within minutes.

                          Subscribe & Save

                          Get lifetime access to our
                          Technavio Insights

                          Customized Report as per your Business Needs

                          • Our analysts will work directly with you and understand your needs
                          • Get data on specified regions or segments, competitor and Vendors
                          • Data will be formatted and presented as per your requirements
                          • We offer $1000 worth of FREE customization at the time of purchase

                          Let us help you make report more suited to your requirements.

                          • Get a competitive breakdown as per your niche industry
                          • Customize the data with various metrics that meet your business prerequisite
                          • Understand Revenue Sources, Customers and many more
                          • Details on Market Share
                          • These customizations are done in a short amount of time by our analysts and industry experts
                          Technavio
                          Enquire Before Buying
                          17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>